Table 1.
Characteristics | Cohort (n = 59) |
---|---|
Age, years—median (IQR) | 73 (67–81) |
Sex | |
Female—n (%) | 26 (44.1%) |
Male—n (%) | 33 (59.1%) |
Race | |
Asian | 2 (3.4%) |
Black | 15 (25.4%) |
Mixed | 17 (28.8%) |
White | 25 (42.4%) |
Reported SARS-CoV-2 infection by RT-qPCR | |
Positive | 37 (62.7%) |
Negative | 22 (37.3%) |
Comorbidities (n, %) | |
Alzheimer’s disease | 1 (1.7%) |
Cerebral palsy | 1 (1.7%) |
Dementia | 14 (23.7%) |
Dysmobility syndrome | 13 (22.0%) |
Hypertension | 9 (15.2%) |
Leprosy | 1 (1.7%) |
Rheumatic fever | 1 (1.7%) |
Schizophrenia | 4 (6.8%) |
Sequalae of Traumatic Brain Injury (TBI) or stroke | 10 (16.9%) |
Type 2 diabetes mellitus (T2DM) | 2 (3.4%) |
None | 4 (6.8%) |